Countdown to 2026

Icon 1

Australian first
The only facility of its kind servicing the medtech and biotech sectors

Icon 2

Early-stage Clinical Trials
Onshore accelerated translation of new medicines, diagnostics and devices

Icon 3

Open to all
Welcoming TRI partners and external researchers

Icon 3

cGMP
Current Good Manufacturing Practice compliance and onsite training 

Icon 3

Know-how
Infrastructure and processes managed by experienced cGMP and quality staff 

 


 

Scale-up Biomedical Manufacturing Capability


 

Due to open in 2026, TRI’s Translational Manufacturing facility will provide the necessary infrastructure to enable MedTech and BioTech businesses to mature and scale-up their manufacturing on Australian shores. It will attract a range of industry, from local start-ups and SMEs to international biomedical companies, delivering the first Australian facility to provide access to cGMP facilities. 

 
 
Descriptive Alt Text
Headshot

“I’m looking forward to helping deliver what will be a state‑of‑the‑art biomedical hub for Australia with global significance. The addition of TM@TRI will make TRI the largest end-to-end translational research facility of its kind in Australia.”
David Crowley, General Manager - Translational Biomedical Manufacturing
 
 
 

At a glance...
 

$100m

Proudly invested by TRI and the Queensland Government

$37m

World class state-of-the-art equipment

500

Highly skilled science jobs

Demand

High pre-opening occupancy demand and EOI

Benefits

For every $1 invested $1.51 flows to the community

 


A new state of the art biomedical hub for Australia

 

TRI’s Translational Manufacturing facility (TM@TRI) will provide infrastructure, support and services at a greater scale to allow the start‐up companies born from local research discoveries to expand into scale‐up spaces. 

Descriptive Alt Text

Facilities and Services

 
  • Co-working desk spaces including meeting rooms and pitch spaces
  • An Innovation space to support light engineering and chemistry
  • Permitted PC2 laboratories
  • Fridge, Freezer and Cryo storage farms
  • Storage space and specialist support spaces for pre-post manufacturing
  • cGMP cleanrooms and manufacturing facilities
    • 5 Cleanrooms - independent air handling
    • ISO 7 (GradeB) capable cleanrooms
    • PC2 regulatory compliant construction
    • cGMP autoclave
    • Environmental Monitoring System (EMS) – 21CFR/Annex 11 compliant
  • QC Lab/Microlab
  • Washroom
  • 24/7 critical systems monitoring, on-site security, swipe card restricted access to all rooms
  • Waste management
  • As part of the TRI campus, easy access to all TRI facilities, services and support including our dedicated Clinical Trial facility at the Princess Alexandra Hospital
 
 
Descriptive Alt Text

TRI and TM@TRI will:

  • Service the biomedical sciences ecosystem.
  • Encourage innovation through good science and good business.
  • Strengthen and protect Australia’s global position in the biomedical sciences.
  • Accelerate the commercialisation of promising treatments, therapies and cures that will improve patient care.
  • Create jobs and drive economic and STEM workforce development.

     

Express your interest

Discover the benefits of basing your business at Australia’s largest end-to-end translational research facility.
Sign up to learn more.
 

SIGN UP